Symphony Financial, Ltd. Co. Zoetis Inc. Transaction History

Symphony Financial, Ltd. Co.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 12, 2021	SELL	$189.29 - $209.69 $232,069 - $257,079	-1,226 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$155.9 - $187.99 $191,133 - $230,475	1,226 New	1,226 $229,000
Q1 2021 Apr 15, 2021	SELL	$144.0 - $169.39 $561,312 - $660,282	-3,898 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$157.07 - $174.35 $54,189 - $60,150	345 Added 9.71%	3,898 $638,000
Q3 2020 Oct 09, 2020	SELL	$137.1 - $165.37 $8,774 - $10,583	-64 Reduced 1.77%	3,553 $588,000
Q2 2020 Jul 08, 2020	BUY	$111.92 - $142.53 $404,814 - $515,531	3,617 New	3,617 $496,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.